These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6174764

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
    Unger T, Yukimura T, Marin-Grez M, Lang RE, Rascher W, Ganten D.
    Eur J Pharmacol; 1982 Mar 26; 78(4):411-20. PubMed ID: 6281036
    [Abstract] [Full Text] [Related]

  • 5. [Combined effect of (2R, 4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarbo xyl ic acid (SA446) with hydrochlorothiazide or propranolol on development of hypertension in spontaneously hypertensive rats (SHR) by long-term administration].
    Takada T, Nakata K, Yamauchi H, Iso T.
    Nihon Yakurigaku Zasshi; 1986 Mar 26; 87(3):331-7. PubMed ID: 3710315
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive mechanism of an angiotensin converting enzyme inhibitor, SA446, in dogs.
    Nishimura K, Okunishi H, Miyazaki M.
    Bull Osaka Med Coll; 1989 Nov 26; 35(1-2):29-37. PubMed ID: 2486241
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Antihypertensive effects of SA446, hydralazine and the combination on renal hypertensive rats and spontaneously hypertensive rats by long-term treatment].
    Nakata K, Nishimura K, Takada T, Yamauchi H, Iso T.
    Nihon Yakurigaku Zasshi; 1986 Feb 26; 87(2):113-21. PubMed ID: 3699625
    [Abstract] [Full Text] [Related]

  • 9. Potentiating mechanism of bradykinin action on smooth muscle by sulfhydryl compounds.
    Iso T, Nishimura K, Oya M, Iwao J.
    Eur J Pharmacol; 1979 Mar 01; 54(3):303-5. PubMed ID: 428428
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [High-performance liquid chromatography of organosulfur compounds using the postcolumn ligand exchange reaction with iodoplatinate. Application to the simultaneous determination of (2R,4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidine carboxylic acid (SA446), an angiotensin converting enzyme inhibitor and its urinary metabolites].
    Horiuchi M, Takashina H, Fujimura K, Iso T.
    Yakugaku Zasshi; 1986 Nov 01; 106(11):1028-33. PubMed ID: 3031265
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril.
    Yamauchi H, Nishimura K, Nakata K, Suda H, Iso T, Shimizu M, Hiramatsu Y.
    Arzneimittelforschung; 1987 Feb 01; 37(2):157-64. PubMed ID: 3034298
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM, Sweet CS, Ulm EH, Backlund EP, Morris AA, Weitz D, Bohn DL, Wenger HC, Vassil TC, Stone CA.
    J Pharmacol Exp Ther; 1981 Mar 01; 216(3):552-7. PubMed ID: 6259322
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.